Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Alaunos Therapeutics Stock Is Tumbling Today

TheMotleyFool

0 0

Why Alaunos Therapeutics Stock Is Tumbling TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Alaunos Therapeutics (NASDAQ: TCRT), a clinical-stage T-cell receptor (TCR) therapy company, is in retreat mode. Specifically, the biotech's share price fell by as much as 10.1% during Monday's trading session.

Shares have recovered to some degree since, but this small-cap biotech stock was still lower by a hefty 8.58% as of 3:48 p.m. ET.

What's weighing on Alaunos' shares today? Alaunos' stock roared higher last week by a whopping 64.4%, thanks to an upcoming medical conference presentation titled "Objective clinical response by KRAS mutation-specific TCR-T cell therapy in previously treated advanced Non-small cell lung cancer."

Source Fool.com

Like: 0

TCRT

Teilen